Emergent BioSolutions Market Cap

Emergent BioSolutions has a market cap or net worth of 306.10 million as of September 17, 2025. Its market cap has decreased by -14.54% in one year.

Market Cap

306.10M

Enterprise Value

605.65M

Revenue

621.58M

Ranking

n/a

PE Ratio

3.01

Stock Price

8.23

Market Cap Chart

Since November 15, 2006, Emergent BioSolutions's market cap has increased from 169.95M to 306.10M, an increase of 80.11%. That is a compound annual growth rate of 3.17%.

Market Cap History

Date	Market Cap	% Change
Sep 16, 2025	306.10M	-26.02%
Dec 31, 2024	413.76M	323.24%
Dec 29, 2023	97.76M	-80.01%
Dec 30, 2022	488.99M	-71.69%
Dec 31, 2021	1.73B	-50.34%
Dec 31, 2020	3.48B	65.40%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	182.89B
GSK plc	59.54B
Haleon	31.92B
Smith & Nephew	12.02B
ConvaTec Group	4.70B
Hikma Pharmaceuticals	3.56B
HUTCHMED (China)	2.23B
Genus	1.65B

Market Cap Rankings